Chinese researchers develop immunotherapeutic agent for colon cancer
Time:2024-05-01 04:27:37 Source:businessViews(143)
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
share to:
Previous:CRAIG BROWN: The killer who wants to be Donald Trump's running mate
Next:Refugee agency chief warns that the number of Syrians leaving Lebanon is likely to rise
Kind tips:The above content and pictures are compiled from the Internet and are for reference only. I hope they will be helpful to you! If there is any infringement, please contact us to delete it.!
You may also like
- Iran commutes a tycoon's death sentence to 20 years in prison
- Local Villagers in SW China's Guizhou Busy Picking Tea Leaves
- Rural Women in SW China's Guizhou Make Creative Cultural Products to Increase Income
- East China City Makes Progress in Building Child Friendly City
- French cops drag pro
- Martial Arts Enthusiasts Found Training Class for Local Children
- Autumn Harvest in Full Swing Across China
- Hong Kong Launches English Version of 1st Volume of Local Chronicles
- Using a walker boot for too long may mean you can't ever walk properly without it again